Optimising malignant melanoma management in Europe
EUMelaReg collects health information to improve care and treatment for patients with skin cancer
Sustaining and fostering collaboration between academia and industry
for the collection of baseline, treatment and outcome data of representative samples of malignant melanoma patients of major European countries.
Building the largest and quickest melanoma registry in the world
EUMelaReg collects real-world data on melanoma patients throughout Europe and integrates them in a data warehouse.

The European Melanoma Registry

EUMelaReg collects real-world data from melanoma patients throughout Europe and securely integrates these datasets in a common database.

Geographical coverage

Geographical coverage


Datasets available


Participating countries

News & Events

EUMelaReg website: new section "Publications"

We are pleased to inform you that we have set up a new "Publications" area on our website. This section offers an insight into EUMelaReg scientific projects and publications. The poster of the EUMelaR...

EUMelaReg ADJU-SEQ poster presented at ESMO congress 2023

As part of the EUMelaReg ADJU-SEQ project a subanalysis was performed and accepted for poster presentation at the ESMO Congress 2023 in Madrid (Abstract title: Efficacy of immune checkpoint inhibition...

EUMelaReg Annual Meeting in Madrid

This year, the Annual Meeting took place on the day before the ESMO Congress in Madrid and is now an established event at which EMR members exchange information. The meeting focus was on the presentat...

New member in the European Melanoma Registry: Welcome Albania

We are pleased to announce that another country has joined the European Melanoma Registry: we warmly welcome Albania on board. We look forward to sharing knowledge, experience and collaboration with o...

EUMelaReg PD-SEQ project accepted at SMR congress 2023

We are pleased to report that the EUMelaReg PD-SEQ project abstract has been accepted for poster presentation at the upcoming Society for Melanoma Research 20th International Congress 2023 in Philadel...

EUMelaReg ADJU-SEQ subanalysis accepted at ESMO congress 2023

As part of the EUMelaReg ADJU-SEQ project a subanalysis was performed and submitted as an abstract to the ESMO Congress. We are pleased to announce that this subanalysis has been accepted for poster p...

Join us!

Collecting real-world data from melanoma patients across Europe, we aim to build the largest and quickest melanoma registry in the world. Interested societies or cancer treatment centres can help us by joining EUMelaReg – even without an existing registry.

“While the total number of cancer incidences is dropping, the number of cases of melanoma is increasing at a rate of 3-7% in many European countries. We need to analyse more data in order to improve diagnosis and develop novel therapies.”

Lidija Kandolf, Serbia

“A rapidly accumulating and massive high-quality real-life data can be obtained only when hands are joined. The conclusions we get from analysing such data allow us to better understand skin cancers and treatment effects. It allows us to formulate burning and important clinical questions and receive the results promptly, in real-time. This is a huge advantage that takes us one step further toward curing cancer. I'm proud to take part in this international collaborative project!”

Nethanel Asher, Israel

“Our advances and success in melanoma research are the result of a true team effort including international collaborations. World class cancer registries are highly needed for patient stratification strategies, as well as in order to translate the results of clinical trials in unselected patient populations and monitor patient care.”

Johanna Mangana, Switzerland

“Real-world data is crucial to validate clinical trial data. Generally, patients enrolled in clinical trials are selected in comparison to patients treated in real life (who are often in worse condition). Analysing data from a large number of real-life patients allows us to assess the true impact of new therapies in clinical practice. This is why a clinical registry such as the European Melanoma Registry is essential.”

Paolo Ascierto, Italy

“In recent years, we have witnessed revolutionary breakthroughs in treatment as well as rejuvenation of patients with melanoma, which poses new challenges for us. EUMelaReg has evolved into a valuable and even more powerful platform for in-depth analysis of clinical practice so far, enabling us to achieve better understanding and successful management of the condition. We are delighted to contribute to global knowledge with data from our real-world practice in Bulgaria.”

Iva Gavrilova, Bulgaria

“Being part of European Melanoma Registry enables us to gain deeper knowledge that not only refines our diagnosis and treatment strategies but by prioritizing accurate data, we also aim to significantly improve the quality of life and increase the survival rates of melanoma patients.”

Ermira Vasili


Implementation of national registries

Provision of infrastructure

Data analysis through reknowned experts

Improved diagnosis and treatment



German Skin Cancer Society


Spanish Multidisciplinary Melanoma Group


Dutch Melanoma Treatment Registry


Danish Oncology Melanoma Database


Central South Eastern European Melanoma Expert Group


Romanian Melanoma Registry


Swiss Melanoma Registry


Polish Society of Surgical Oncology


Hellenic Society of Medical Oncology


Clinical National Melanoma Registry


Bulgarian Association of Dermato-Oncology

Ella Lemelbaum Institute for Immuno-Oncology and Melanoma


Albanian Melanoma Registry